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ABSTRACT
Bromodomain-containing protein Brd4 is shown
to persistently associate with chromosomes during
mitosis for transmitting epigenetic memory across
cell divisions. During interphase, Brd4 also plays a
key role in regulating the transcription of signal-
inducible genes by recruiting positive transcrip-
tion elongation factor b (P-TEFb) to promoters.
How the chromatin-bound Brd4 transits into a tran-
scriptional regulation mode in response to stimula-
tion, however, is largely unknown. Here, by
analyzing the dynamics of Brd4 during ultraviolet
or hexamethylene bisacetamide treatment, we
show that the signal-induced release of chromatin-
bound Brd4 is essential for its functional
transition. In untreated cells, almost all Brd4 is
observed in association with interphase chromatin.
Upon treatment, Brd4 is released from chromatin,
mostly due to signal-triggered deacetylation of
nucleosomal histone H4 at acetylated-lysine 5/8
(H4K5ac/K8ac). Through selective association with
the transcriptional active form of P-TEFb that has
been liberated from the inactive multi-subunit
complex in response to treatment, the released
Brd4 mediates the recruitment of this active
P-TEFb to promoter, which enhances transcription
at the stage of elongation. Thus, through signal-
induced release from chromatin and selective asso-
ciation with the active form of P-TEFb, the
chromatin-bound Brd4 switches its role to mediate
the recruitment of P-TEFb for regulating the tran-
scriptional elongation of signal-inducible genes.
INTRODUCTION
The regulation of the processivity of RNA polymerase
(Pol) II is recognized as a key mechanism for controlling
the expression of vast arrays of signal-inducible genes in
metazoan (1,2). Shortly after transcriptional initiation,
RNA Pol II pauses at the promoter-proximal region.
The positive transcription elongation factor b (P-TEFb),
a heterodimeric kinase predominantly composed of Cdk9
and Cyclin T1, promotes the transition of Pol II from
pausing to processive mode by phosphorylating the
C-terminal domain (CTD) of the largest subunit of Pol
II, thereby leading to the synthesis of full-length tran-
scripts (3,4). Hence, the availability of P-TEFb activity
at promoter-proximal region is crucial for the expression
of inducible genes. In cells, the activity of P-TEFb is
tightly regulated (5,6). In actively growing cells, the
majority of P-TEFb is sequestered in an inactive 7SK
small nuclear ribonucleoprotein (snRNP) complex that
also contains 7SK snRNA (7,8), HEXIM1/HEXIM2
(9–12), LARP7 (13,14) and MePCE/BCDIN3 (15–17).
Upon stimulation by various signals, P-TEFb is liberated
from the inactive complex, mostly due to the
dephosphorylation at T-loop of Cdk9, the catalytic
subunit of P-TEFb (5,18,19).
The efﬁcient transcription of signal-inducible genes,
however, relies not only on P-TEFb’s liberation from
the inactive complex, but also on its recruitment to pro-
moters. Currently, bromodomain-containing protein
Brd4, which belongs to the bromodomain and
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ET-domain (BET) protein family (20,21), is recognized as
the most important general factor for P-TEFb recruitment
(20–23). The two bromodomains of Brd4 are necessary
and sufﬁcient for its association with acetylated tails of
histone H3 and H4 (24,25). In addition, a P-TEFb inter-
acting domain (PID) located at the very C-terminus of
Brd4 is essential for its binding to P-TEFb (26,27). The
function of the ET domain is just being recognized as a
region interacting with WHSC1L1/NSD3 for P-TEFb-
independent regulation of H3K36 methylation (28).
Originally termed mitotic chromosome associated
protein (MCAP), Brd4 is found to be persistently asso-
ciated with acetylated chromosomes during mitosis in a
number of cell lines (24,25), which is critical for the re-
cruitment of P-TEFb and the rapid expression of early G1
genes upon exiting mitosis (29–31). Thus, Brd4 is
proposed to play an important role in transmitting epigen-
etic memory across cell divisions (29–31).
In addition to the relatively stable chromatin targeting
of Brd4, its dynamic association with chromatin has been
observed in multiple systems as well (32). For instance,
signal-induced Brd4 occupancy at promoters has been
shown to be crucial for the expression of a vast array of
primary response genes both in lipopolysaccharide-
stimulated macrophages (33) and in mitogen-activated
Jurkat T cells (34). Moreover, a recent study revealed
that subsequent to histone H3S10 phosphorylation and
H4K16 acetylation, the binding of Brd4 to FOSL1
intronic enhancer is increased in serum-stimulated
HEK293 cells (35). These observations indicate that
Brd4 is dynamically redistributed to regulate gene expres-
sion under different circumstances.
How Brd4 transits from chromatin targeting to tran-
scriptional regulation in response to stimulation,
however, is not well understood (20). Here, by analyzing
the chromatin-bound and -free fractions, we show that
almost all Brd4 is associated with interphase chromatin in
untreated cells. Upon ultraviolet (UV) or hexamethylene
bisacetamide (HMBA) treatment, Brd4 is released from
chromatin through signal-induced histone deacetylation,
and this release is essential for P-TEFb recruitment to
promoter and transcriptional elongation. Combined with
previous studies (19,36), we propose a model in which the
stimulation triggers the liberation of P-TEFb from the
inactive 7SK snRNP complex, and the release of Brd4
from chromatin, thereby switching the role of Brd4 from
chromatin targeting to P-TEFb recruitment for the efﬁ-
cient elongation of inducible genes.
MATERIALS AND METHODS
Chemicals
Hexamethylene bisacetamide (HMBA) (Cat#:
224235-50G, Batch#:01907JR) is from Sigma.
Trichostatin A (TSA) and suberoyl bishydroxamic acid
(SBHA) are from Calbiochem. Ethylenediaminetetraacetic
acid (EDTA)-free complete protease inhibitor cocktail is
from Roche. DNase I, SYBR Green Realtime PCR
Master Mix Plus and the ReverTra Ace qPCR RT Kit
are from Toyobo Co. Japan. All other chemicals are
from Amresco or Merck.
Antibodies
Rabbit anti-Sp1 (sc-5286), histone H3 (sc-59) and mouse
anti-a-Tubulin (sc-10809) antibodies are from Santa Cruz.
Mouse anti-b-Actin (A2228) antibody, mouse anti-HA
agarose beads (A2095) and anti-Flag M2 afﬁnity gel
(A2220) are from Sigma. Rat anti-HA antibody is from
Roche. Rabbit anti-histone H4 (05-858), H4K5ac
(07-327), H4K8ac (07-328), H4K12ac (07-595), H4K16ac
(06-762), H3K9/14ac (06-599), H3K4me3 (07-473) and
H3K27me3 (07-449) are from Millipore. Rabbit
anti-H3K36me3 (ab9050) is from Abcam. Rabbit
anti-Cdk9, Cyclin T1 and HEXIM1 antibodies were
raised in GeneScript (Nanjing, China) against the follow-
ing peptides: RRKGSQITQQSTNQ (Cdk9, amino acids
343–356), SGNTDKPRPPPLPS (Cyclin T1, amino acids
702–715) and HRQQERAPLSKFGD (HEXIM1, amino
acids 346–359). Rabbit anti-Brd4 and Cdk9-pT186
antibodies were reported previously (19).
Plasmids
The constructs containing P-TEFb interaction domain
(HA-PID, amino acids 1260–1362) (26) or N-terminal
fragment (HA-C, amino acids 1–721) of Brd4 were
generated by inserting the respective polymerase chain
reaction (PCR)-ampliﬁed complementary DNA (cDNA)
fragments from pcDNA4c-huBrd4 (Addgene Plasmid
14441, with full-length human Brd4 cDNA) (37) into
BamH I/Xba I sites of modiﬁed pcDNA3-HA or -Flag
vector, and was conﬁrmed by DNA sequencing. The
plasmid with the short hairpin RNA (shRNA) targeting
human Brd4 was reported previously (22).
Cell lines
HeLa cells, the HeLa cell with an integrated HIV-1
LTR-luciferase reporter gene (19) and the HeLa-based
stable cell lines were maintained as reported previously
(11,22). All other cell lines (Supplementary Figure S1)
were maintained according to American Type Culture
Collection (ATCC) instructions.
Treatment of cells with UV or various pharmacological
compounds
Cells at 50–70% conﬂuence were pre-incubated with
histone deacetylase (HDAC) inhibitor TSA (400 nM) or
SBHA (200 nM) for 1 h, followed by a treatment with
10mM HMBA for 4 h, unless indicated otherwise. For
UV irradiation, cells were exposed to 80 J/m2 of UV in
Spectrolinker XL-1000 (Spectronics) without culture
medium, followed by an incubation in the original
medium for 30min (19). After treatments, the cells were
subjected to nuclear fractionation immediately.
Modiﬁed nuclear fractionation
Cells were harvested and washed twice with ice-cold
phosphate-buffered saline (PBS) and centrifuged at
1500g, 4C for 5min, and the packed cell volume (PCV)
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was recorded. The cells were suspended in 5PCV of
ice-cold buffer A (10mM HEPES pH 7.9/1.5mM
MgCl2/10mM KCl/1mM DTT/0.5mM PMSF/1prote-
ase inhibitor cocktail) for 10min. The swollen cells were
centrifuged, and the cell pellet was subjected to low-salt
extraction by resuspending in 2PCV of buffer A (with
1% NP-40) for 10min to break the cell membrane. The
nuclei were centrifuged at 5000g, 4C for 5min and the
supernatant (3.6PCV) was saved. The nuclei were
further extracted twice by resuspending in 1PCV of
buffer A (with 0.5% NP-40/75mM NaCl) for 5min
followed by centrifugation. The supernatants of the
three extractions were combined, and saved as the low-salt
fraction (LSF, 5.6PCV). Subsequently, the nuclei were
subjected to high-salt extraction with 6PCV of high-salt
buffer (10mM HEPES pH 7.9/20% glycerol/0.3M NaCl/
1.5mM MgCl2/0.4mM EDTA/0.5% NP40/1mM DTT/
0.5mM phenylmethylsulfonyl ﬂuoride (PMSF)/1prote-
ase inhibitor cocktail) on a rotator at 4C for 30min.
The nuclei were centrifuged at 12 000g at 4C for 10min
and the supernatant was saved as the high-salt fraction
(HSF, 6.2PCV). The volume and salt concentration
of LSF were brought to the same as those of HSF. The
remnant nuclear pellet was boiled in 6PCV of sodium
dodecyl sulfate (SDS)-loading buffer. The LSF and HSF
were stored at 80C, or used directly.
DNase I digestion of nuclei
Brieﬂy, 1–2 107 HeLa cells were subjected to three
rounds of low-salt extraction as described above, and
the nuclei were equilibrated with 500 ml of 1DNase I
digestion buffer (40mM Tris–HCl pH 7.5/8mM MgCl2/
5mM DTT/1 protease inhibitor cocktail) and
centrifuged at 5000g, 4C for 5min. The nuclei were
incubated with 100U of DNase I in 100 ml of 1DNase
I digestion buffer at 30C for 1.5 h, followed by centrifu-
gation at 10 000g, 4C for 5min. The supernatant was
saved. A portion of digested nuclei was lysed with
SDS-loading buffer and the rest was subjected to DNA
isolation. The proteins in the supernatant and nuclear
lysate were detected by western blotting and the isolated
chromatin DNA was analyzed by ethidium bromide
staining after agarose gel electrophoresis.
Salt-titrated extraction assay
The salt-titrated extraction was performed to test the
strength of Brd4’s interaction with chromatin. Cells were
extracted with low-salt buffer for three times to remove
chromatin-free P-TEFb and its related factors. The
low-salt extracted nuclei (LSENs) were then extracted
with 6PCV of high-salt buffer with indicated concentra-
tion of NaCl. After centrifugation at 12 000g, 4C for
10min, the supernatants were saved as nuclear extracts
(NEs) and the pellets were boiled in SDS-loading buffer
to yield nuclear lysate fractions.
Immuno-afﬁnity puriﬁcation
Flag-tagged protein and its associated factors were
isolated by anti-Flag Immuno-afﬁnity puriﬁcation (IP)
from NE, LSF or HSF of HeLa-based stable cells F1C2
(expressing Cdk9-Flag) (36), MCAP (HA-Brd4-Flag) (22)
and HH8 (Flag-HEXIM1) (11) or transfected HeLa cells
as described previously (38). The levels of proteins
indicated in ﬁgures were determined by western blotting.
Luciferase assay
HeLa cells with an integrated HIV-LTR luciferase
reporter gene (HIV-LTR-Luc) (19,39) were pre-incubated
for 1 h with the indicated amount of HDAC inhibitors in
six-well plates, followed by 6 h of incubation with 10mM
HMBA. Cells lysates were prepared to measure luciferase
activity (19). The error bars were calculated based on three
independent experiments.
Chromatin immunoprecipitation
Chromatin immunoprecipitation (ChIP) was carried out
with HIV-LTR-Luc integrated HeLa cells as described
previously (38). Immunoprecipitated DNA was analyzed
by real-time PCR with SYBR Green Realtime PCR
Master Mix Plus (Toyobo) and primers in HIV-LTR
promoter region (111 to 31, forward: 50-GCT ACA
AGG GAC TTT CCG CTG G, reverse: 50-AGG ATC
TGA GGG CTC GCC ACT). The PCR ampliﬁcation
was performed on Eppendorf Mastercycler ep realplex2
with the following program: 95C for 2min followed by
35 cycles of 10 s at 95C, 15 s at 60C for annealing and
20 s at 70C for extension. The results from two independ-
ent experiments were averaged and plotted as percentage
of input.
Quantitative real-time-PCR
Total RNA was isolated from HeLa cells with an
integrated HIV-LTR-Luc with Trizol (Invitrogen), and
2 mg of the RNA was digested with DNase I followed by
phenol/chloroform extraction. The puriﬁed RNA was
reverse-transcribed with ReverTra Ace qPCR RT Kit
(Toyobo) in a total volume of 10 ml. For real-time PCR
ampliﬁcation, 2 ml of cDNA were used as template, with
same conditions described in ChIP section. The
HIV-LTR-Luciferase expression level was normalized to
that of b-actin. Data were represented as fold enrichment
compared to untreated sample. The error bars were
calculated based on three independent experiments (38).
The primers were as follows: HIV-LTR-Luciferase (+1 to
+59, forward: 50-GGG TCT CTC GAG TTA GAC CAG
ATC TGA, reverse: 50-GGG TTC CCT AGT TAG CCA
GAG AGC; and +468 to +593, forward: 50-CGC AGC
CTA CCG TAG TGT TTG, reverse: 50-ACT GAA ATC
CCT GGT AAT CCG TT), and b-actin (forward: 50-ATC
GTC CAC CGC AAA TGC TTC TA, reverse: 50-AGC
CAT GCC AAT CTC ATC TTG TT).
RESULTS
Separation of chromatin-bound and -free P-TEFb
and its related components
To study the chromatin recruitment of P-TEFb by Brd4,
we developed a modiﬁed nuclear fractionation (MONF)
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protocol based on Dignam’s nuclear extraction method
(40) and the concept of differential extraction (25,41)
for fractionating the chromatin-bound and -free
P-TEFb and its related components in HeLa cells (see
‘Material and Methods’ section, Figure 1A). After three
rounds of extraction with a low-salt buffer containing
75mM NaCl, HEXIM1, a component of the
inactive 7SK snRNP complex, was completely extracted
into the LSF (Figure 1B, lane 1), indicating that
the chromatin-free components related to P-TEFb can
be completely removed from nuclei by this procedure.
Remarkably, almost all Brd4 was extracted into the
HSF that contained 0.3M NaCl (Figure 1B, lane 2).
P-TEFb showed a different distribution, for about
70–80% P-TEFb extracted into LSF, with the remaining
Cyclin T1 and Cdk9 extracted into HSF (Figure 1B).
Of note, the P-TEFb in LSF was fully sequestered in the
inactive 7SK snRNP complex, as demonstrated by that
Cyclin T1, which is the less abundant subunit of
P-TEFb, was completely removed by anti-HEXIM1 and
anti-LARP7 depletion of LSF (Supplementary Figure
S2A, left).
To test whether the nuclear P-TEFb and Brd4 observed
in HSF were those associated with chromatin, we per-
formed DNase I digestion of LSENs, with RNasin treat-
ment as a control (see ‘Material and Methods’ section,
Figure 1A). When chromatin DNA was fully degraded
(Figure 1C, left panel, lane 2), Sp1, a sequence-speciﬁc
DNA-binding protein, was released into the supernatant,
whereas Lamin B, a nuclear matrix protein, remained in
the nucleus (Figure 1C, right panel). Both Brd4 and
P-TEFb in LSENs were completely released into super-
natant upon DNase I digestion (Figure 1C, right panel,
lane 2 and 4), indicating that similar to Sp1, their presence
in the LSENs depends on their association with chroma-
tin. As Brd4 and P-TEFb in LSENs could also be fully
extracted into HSF with 0.3M NaCl (Figure 1B, lane 2),
therefore, the factors detected in HSF represent the
Figure 1. Almost all Brd4 is associated with chromatin in HeLa cells. (A) Schematics for modiﬁed nuclear fractionation (MONF) and DNase I
digestion procedures. HeLa cells are suspended in buffer A, and the swollen cells are extracted three times with a low-salt buffer to yield low-salt
fraction (LSF). The low-salt extracted nuclei (LSENs) are further extracted with a high-salt buffer to obtain high-salt fraction (HSF). Finally, the
nuclear pellet is boiled in SDS-loading buffer, and saved as nuclear lysate fraction (NLF). Before further analysis, LSF, HSF and NLF are adjusted
to the same volume and salt concentration. To verify that P-TEFb and its related factors in HSF reﬂected chromatin-bound components, LSENs are
digested with DNase I and the supernatant is saved, whereas the nuclear pellet is subjected either to DNA isolation or to nuclear lysis. (B) The LSF,
HSF and NLF fractions prepared from HeLa cells were analyzed by western blotting (WB) for the indicated proteins. (C) DNase I digestion assay of
LSENs. Proteins in the supernatant and nuclear lysate after DNase I digestion of LSENs were analyzed by WB (right), and chromatin DNA was
analyzed on ethidium bromide (EB) stained agarose gel (Left), with RNasin treatment as a control.
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chromatin-bound population and those in LSF reﬂect the
chromatin-free factors.
Almost all Brd4 targets to interphase chromatin
Brd4 has been shown targeting to chromosomes during
mitosis (24). The detection of the vast majority of Brd4
in HSF indicated that almost all Brd4 also targets to inter-
phase chromatin in HeLa cells (Figure 1B). To test
whether it is a general phenomenon, we examined 10
randomly chosen human and mouse cell lines of different
origins (Supplementary Figure S1). In all of them, it was
consistently observed that almost all Brd4 is associated
with chromatin, suggesting that chromatin targeting is a
general property of Brd4 in mammalian cells.
UV or HMBA treatment induces the release of Brd4
from chromatin
Brd4 plays a key role in recruiting P-TEFb to promoters
for genes’ expression (22,23). Given that almost all Brd4 is
already associated with chromatin in cells, we wondered
how the chromatin-bound Brd4 mediates the recruitment
of P-TEFb to gene promoters, especially those of the
signal-inducible genes where increased P-TEFb occupancy
is detected at the promoters upon stimulation (22,23). We
therefore analyzed the distribution of Brd4 in chromatin-
bound versus -free fractions of UV- or HMBA-treated
cells. Interestingly, a signiﬁcant portion of Brd4
appeared in LSF with a concomitant reduction of Brd4
in HSF of stimulated cells (Figure 2A), indicating that
Brd4 was released from chromatin upon treatment.
Although a large portion of Brd4 still remained on chro-
matin in the treated cells (HSF in Figure 2A and DNase I
digestion assay in Supplementary Figure S2B), the
salt-titrated extraction assay showed that 0.2M NaCl
was sufﬁcient to remove all Brd4 from chromatin in
treated cells instead of the 0.3M salt required for the un-
treated cells (Figure 2B). These results suggested that the
UV or HMBA treatment weakened the interaction of
Brd4 with chromatin and thereby induced Brd4 release
from chromatin.
Of note, after the removal of HMBA, the level of Brd4
in LSF was gradually reduced, and most Brd4 was gone
from the chromatin-free fraction by 2 h (Figure 2C). Since
total cellular levels of Brd4 did not change either during
HMBA treatment or after HMBA removal (Figure 2C,
bottom), the reduction of Brd4 in LSF indicated that the
signal-released Brd4 re-associated with chromatin after
HMBA withdraw. Thus, these data indicate that chroma-
tin targeting is the default feature of Brd4 in untreated
cells.
UV or HMBA treatment increases the levels of
Brd4/P-TEFb complex in both chromatin-bound and
-free fractions
Next, we asked whether the signal-released Brd4 plays a
role in recruiting P-TEFb. It was noteworthy that upon
UV or HMBA treatment, a portion of P-TEFb shifted
from LSF to HSF (Figure 2A), suggesting an increased
recruitment of P-TEFb to chromatin. Therefore, we
analyzed the levels of Brd4 and its associated P-TEFb in
both the chromatin-bound and -free fractions in MCAP
cells, a HeLa-based cell line stably expressing
HA-Brd4-Flag, after anti-Flag afﬁnity puriﬁcation with
excess amount of anti-Flag antibody (Figure 3A). In un-
treated cells, a trace amount of chromatin-free Brd4 and
its associated P-TEFb was detected in LSF (Figure 3A,
lane 1). Upon UV or HMBA treatment, the levels of Brd4/
P-TEFb complex in LSF was dramatically elevated
(Figure 3A, lanes 2 and 3), presumably due to the
increased availabilities of both Brd4 that is released
from chromatin (Figure 2A) and P-TEFb that is librated
from the inactive 7SK snRNP complex (Supplementary
Figure S2A, right) (19). Concomitantly, more Brd4/
P-TEFb complex was also detected in HSF upon UV
and HMBA treatment (Figure 3A, compare lanes 5 and
6 with lane 4).
Both the chromatin-bound and signal-released Brd4
associates with P-TEFb that contains
phosphorylated Cdk9-T186
The phosphorylation of T-loop of Cdk9 at Thr186
(Cdk9-pT186) is crucial for P-TEFb’s kinase activity
during transcription elongation (19,36). In UV- or
HMBA-treated cells, however, the signal-induced liber-
ation of P-TEFb from the inactive 7SK snRNP complex
occurs after the dephosphorylation of Cdk9-pT186 (19).
To examine the phosphorylation levels of the chromatin-
free and -bound portions of P-TEFb, we fractionated
F1C2 (stably expressing Cdk9-Flag) cells into LSF and
HSF, and measured the extent of T186 phosphorylation
by western blot analysis using normalized levels of total
Cdk9 (Figure 3B). Consistent with the previous study (19),
the extent of Cdk9-pT186 was dramatically decreased in
LSF of UV- or HMBA-treated cells (Figure 3B, left). In
contrast, high levels of Cdk9-T186 phosphorylation were
detected in HSF from both untreated and treated cells
(Figure 3B, right), indicating that the chromatin-bound
P-TEFb is highly phosphorylated at Cdk9-T186.
Next, we analyzed the phosphorylation state of P-TEFb
that is in association with Brd4, using the
HEXIM1-bound P-TEFb isolated from the LSF of HH8
cells (a HeLa-based cell line stably expressing Flag-
HEXIM1) as a control for the fully phosphorylated
Cdk9-T186 (Figure 3C, lane 1) (19). Surprisingly, fully
phosphorylated Cdk9-T186 was detected for the
Brd4-associated P-TEFb puriﬁed from both chromatin-
bound and -free fractions in UV-treated MCAP (express-
ing HA-Brd4-Flag) cells (Figure 3C, compare lanes 2 and
3 to lane 1). These data indicate that the signal-released
Brd4 selectively associates with the transcriptionally active
form of P-TEFb that has its Cdk9-T186 fully
phosphorylated.
HDAC inhibitor blocks the UV- or HMBA-induced
release of Brd4 from chromatin
Brd4 has been shown to associate with acetylated chroma-
tin via its bromodomains (24,25). To test whether the UV-
or HMBA-induced Brd4 release was achieved through a
reduction in the acetylation levels of chromatin, we pre-
treated cells with histone deacetylase (HDAC) inhibitors.
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As expected, the Brd4 release induced by either UV or
HMBA was markedly thwarted by HDAC inhibitor
TSA (Figure 4A). Signiﬁcantly, SBHA, a hybrid polar
class HDAC inhibitor whose molecular structure is differ-
ent from that of TSA (42), had a similar effect in blocking
the UV- or HMBA-induced Brd4 release from chromatin
(Supplementary Figure S3A). Moreover, the salt-titrated
extraction assay showed that although the majority of
Brd4 was extracted into buffer containing 0.15–0.2M
NaCl in HMBA-treated cells, TSA pretreatment pre-
vented a signiﬁcant portion of Brd4 from being extracted
into these buffers (Figure 4B, compare lanes 7 and 8 with
lanes 2 and 3). Collectively, these data indicate that the
binding of Brd4 to chromatin is greatly stabilized when
deacetylation is inhibited.
HDAC inhibitor blocks stimulation-induced deacetylation
of nucleosomal histone H4K5ac/8ac
Brd4 has been shown to interact with both acetylated
histone tails of H3 and H4 (25). Hence, the release of
Brd4 from chromatin during HMBA or UV treatment is
most likely caused by the deacetylation of nucleosomal
histone H3 and H4. To test this idea, we examined the
modiﬁcation on nucleosomal histones H3 and H4 by
western blot analysis of LSENs with modiﬁcation-speciﬁc
antibodies. Interestingly, after UV or HMBA treatment,
the acetylation levels of nucleosomal histone H4 at
lysine 5 (H4K5ac) and lysine 8 (H4K8ac) were reduced
(Figure 4C, compare lane 1 with lanes 3 and 5, with quan-
tiﬁcation based on three independent experiments in the
bottom panel, which showed a consistent trend of reduc-
tion after treatment). In contrast, the acetylation levels of
histone H4 at lysines 12 and 16 (H4K12ac, H4K16ac)
(Figure 4C) and those of H3 at both lysine 9/14
(H3K9ac/K14ac), as well as the tri-methylation levels of
histone H3 at lysines 4, 27 and 36 (H3K4me3, H3K27me3
and H3K36me3) (Supplementary Figure S3B), were not
affected. As expected, the TSA pretreatment signiﬁcantly
blocked the signal-induced deacetylation of H4K5ac and
H4K8ac (Figure 4C, lanes 4 and 6), suggesting the in-
volvement of HDAC-dependent pathway(s) in HMBA-
or UV-induced release of Brd4 from chromatin.
HDAC inhibitor blocks the Brd4-mediated recruitment of
P-TEFb to chromatin
We reasoned that if the signal-induced Brd4 release from
chromatin is essential for increased formation of Brd4/
P-TEFb complex and its subsequent recruitment to chro-
matin, we should expect that when Brd4 release from
chromatin is blocked, the signal-induced recruitment of
Brd4/P-TEFb complex (Figure 3A) would also be
deterred. To test this idea, we analyzed the levels of
Brd4 and its associated P-TEFb in both the
chromatin-bound and -free fractions in MCAP (stably ex-
pressing HA-Brd4-Flag) cells by immunoprecipitation.
Indeed, as the TSA pretreatment blocked the release of
Figure 2. UV or HMBA treatment induces the release of Brd4 from chromatin. (A) LSF (left) and HSF (right) prepared from the UV- or
HMBA-treated HeLa cells were subjected to western blotting (WB) for the indicated proteins. (B) Salt-titrated extraction assay of HeLa cells
treated with HMBA or UV. The cells were extracted three times with low-salt buffer, and the nuclei were aliquoted and each was extracted with
buffer containing indicated concentrations of NaCl. The nuclear pellets were lysed in SDS-loading buffer and analyzed by WB to determine the
amount of Brd4 remained in chromatin. (C) The levels of released Brd4 in LSF (top) and the total amount of Brd4 in the cells (bottom) were
determined by WB for HeLa cells that were treated with 10mM HMBA for 4 h, and recovered in normal culture medium for the indicated period.
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chromatin-bound Brd4 (Figure 4A and D, LSF), it also
diminished the UV- and HMBA-induced increase in the
levels of Brd4/P-TEFb complex in chromatin-bound frac-
tions (Figure 4D, HSF, compare lanes 10 and 12 with
lanes 9 and 11).
Of note, neither the UV- or HMBA-induced disruption
of 7SK snRNP (Supplementary Figure S3C) nor the asso-
ciation of P-TEFb with a Flag-tagged P-TEFb-interacting
domain of Brd4 (amino acids 1260–1362) (Supplementary
Figure S3D) was affected by TSA pretreatment. The ex-
pression levels of Brd4 and P-TEFb were also unaltered by
these treatments (Supplementary Figure S3E). Therefore,
the inhibitory effect of TSA on the signal-induced recruit-
ment of Brd4/P-TEFb complex to chromatin is most likely
achieved by impeding the Brd4 release from chromatin,
which prevents the increased formation of Brd4/P-TEFb
complex.
HDAC inhibitor blocks the stimulatory effect of HMBA
on HIV-1 transcription
HMBA is a potent inducer for HIV-1 transcription (43),
and HDAC inhibitors such as TSA can also activate
HIV-1 expression (44). Thus, HMBA and HDAC inhibi-
tors may be expected to have an additive effect in boosting
HIV-1 transcription. However, if the release of Brd4 from
chromatin is essential for signal-induced P-TEFb recruit-
ment to chromatin, HDAC inhibitors, which impede Brd4
release from chromatin (Figure 4A and Supplementary
Figure S3A), would prevent HMBA from stimulating
HIV-1 transcription. Therefore, we tested the combined
effects of HDAC inhibitors and HMBA in
HIV-LTR-Luc cells, a HeLa cell line with an integrated
HIV-LTR luciferase reporter gene (19,39). Although TSA
or HMBA individually stimulated HIV-1 promoter-driven
luciferase activity, TSA attenuated the HMBA’s stimula-
tory effect in a dose-dependent manner (Figure 5A). A
similar effect was also observed with a different HDAC
inhibitor, SBHA (Supplementary Figure S4).
Interestingly, quantitative RT-PCR analysis of the tran-
scripts corresponding to the initiation and elongation
regions (Figure 5B, top) (45) indicated that TSA aug-
mented transcription mainly at the stage of initiation,
whereas the stimulatory effect of HMBA occurred
mostly at the stage of elongation (Figure 5B, bottom).
When combined, TSA inhibited the HMBA-induced
HIV-1 transcription speciﬁcally at the stage of elongation,
rather than initiation (Figure 5B), similar to the effect of
Brd4 knockdown by shRNA (Figure 5C).
Figure 3. Both the chromatin-bound and signal-released Brd4 proteins associate with P-TEFb that contains phosphorylated CDK9 T-loop.
(A) Levels of Brd4 and Cdk9 in anti-Flag immunoprecipitates from LSF (left) and HSF (right) of MCAP (HA-Brd4-f stable line) cells with indicated
treatments were analyzed by western blotting (WB). (B) The levels of bulk and T186-phosphorylated (pT186) form of Cdk9 in anti-Flag immunopre-
cipitates derived from LSF (left) and HSF (right) of F1C2 (Cdk9-f stable line) cells treated with UV or HMBA were analyzed by WB. (C) Detection
of Cdk9-T186 phosphorylation levels of Brd4-associated P-TEFb. Proteins were isolated from LSF and HSF of UV-treated MCAP cells by anti-Flag
afﬁnity puriﬁcation. The levels of bulk and pT186 form of Cdk9 and indicated proteins were determined by WB, with HEXIM1-bound P-TEFb
isolated from the LSF of HH8 (f-HEXIM1 stable line) cells as a control for the fully phosphorylated CDk9-T186. The sample volumes were adjusted
to achieve equal loading of Cdk9 for the measurement of pT186 in (B, C).
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To test whether the inhibitory effect of TSA on
HMBA-stimulated HIV-1 transcriptional elongation was
due to the inhibition of Brd4-mediated P-TEFb recruit-
ment to HIV-1 promoter, we performed ChIP assay of
HIV-LTR-Luc cells with anti-Cdk9 antibody. As
expected, whereas HMBA enhanced the recruitment of
P-TEFb onto HIV-1 promoter, this enhancement was
markedly inhibited by TSA (Figure 5D).
Collectively, these data indicate that the signal-induced
release of Brd4 from chromatin is essential for mediating
P-TEFb recruitment to stimulate transcriptional
elongation.
Ectopic expression of the "C-mutant of Brd4 induces
the release of endogenous Brd4 from chromatin and
augments HIV-1 transcription
Although the data presented so far strongly suggest that
signal-triggered Brd4 release from chromatin is critical for
signal-induced elevation in HIV-1 transcription, we,
however, cannot formally exclude the possibility that
HDAC inhibitors and UV/HMBA treatments may inﬂu-
ence transcription by other means. To avoid the side
effects of these treatments, we tested whether the forced
release of endogenous Brd4 from chromatin by the ectopic
expression of HA-C could enhance transcription.
HA-C, a HA-tagged Brd4 mutant (amino acids 1–721),
which contains two bromodomains but lacks the P-TEFb
interaction domain (PID), could associate with chromatin
(Supplementary Figure S5A), but is unable to bind to
P-TEFb (Figure S5B). HA-PID, a mutant that contains
the P-TEFb interacting domain but not the bromo-
domains (amino acids 1260–1362), could associate with
P-TEFb but not chromatin (Supplementary Figure S5A
and B), and was used as a control.
While the ectopic expression of HA-PID did not alter
the level of endogenous Brd4 in LSF (Figure 6A, compare
Figure 4. Impeding Brd4 release from chromatin abolishes Brd4-mediated P-TEFb recruitment. (A) The effect of TSA treatment on
stimulation-induced Brd4 release. Brd4 in LSFs prepared from HeLa cells treated with UV (left) or HMBA (right) either with or without TSA
pretreatment as indicated were analyzed by western blotting (WB). (B) Salt-titrated extraction of HeLa cells treated with TSA and/or HMBA. The
cells were extracted with low-salt buffer to remove chromatin-free Brd4, and subsequently the nuclei were extracted with buffer containing indicated
concentrations of NaCl. The levels of released Brd4 were analyzed by WB. (C) Effect of TSA treatment on stimulation-induced nucleosomal histone
H4 deacetylation. WB analysis of nucleosomal histone H4 acetylation levels (top) with quantiﬁcation (bottom, averaged from three independent
experiments) for HeLa cells treated with UV or HMBA either with or without TSA pretreatment as indicated. (D) Effect of TSA pretreatment on the
levels of UV- or HMBA-induced Brd4/P-TEFb complex. Anti-Flag immunoprecipitates from LSF (left) and HSF (right) of MCAP (HA-Brd4-f
stable line) cells with indicated treatments were analyzed by WB.
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lane 3 with lane 1), the ectopically expressed HA-C
increased the level of endogenous Brd4 in LSF
(Figure 6A, compare lane 2 with lane 1), presumably by
competitive binding of HA-C to chromatin and there-
by displacing a portion of endogenous Brd4 from
chromatin. Accordingly, the ectopic expression of
HA-C, but not HA-PID, also enhanced HIV-1 tran-
scription (Figure 6B), whereas both of them did not
affect the levels of endogenous Brd4, P-TEFb and
HEXIM1 (Supplementary Figure S5C). Taken together,
these data support the notion that the availability of
Brd4 in the chromatin-free state is limiting for gene tran-
scription, and one mechanism for signal-induced tran-
scriptional regulation is by modulating the amount of
Brd4 mobilized from chromatin-bound into chromatin-
free state for the subsequent P-TEFb recruitment and
transcriptional elongation.
DISCUSSION
Combined with previous studies (19,36), the data pre-
sented above are consistent with a model (Figure 7) in
which external signals trigger two parallel events: the lib-
eration of P-TEFb from inactive 7SK snRNP and the
release of Brd4 from chromatin. In untreated cells, most
of the chromatin-free P-TEFb is sequestered in the
inactive 7SK snRNP and almost all Brd4 is associated
with acetylated chromatin. External stimuli, such as
HMBA or UV, trigger the dephosphorylation of Cdk9
T-loop at T186 by the cooperative action of the activated
phosphatases PP2B and PP1a pathways, thereby
liberating P-TEFb from the inactive 7SK snRNP (19).
Meanwhile, the stimuli also induce the deacetylation of
nucleosomal histone H4, and subsequently the release of
Brd4 from chromatin by yet-to-be identiﬁed HDAC-
dependent pathway. Through selective interaction with
Figure 5. HDAC inhibitor blocks HMBA-stimulated HIV-1 transcriptional elongation. (A) Effect of HDAC inhibitor TSA on HMBA-stimulated
HIV-1 expression. Luciferase activities of the cell lysates from HeLa cells with an integrated HIV-1 LTR-luciferase gene that were pretreated with the
indicated amounts of TSA before incubated with HMBA were plotted based on three independent experiments. (B) The levels of transcripts
corresponding to the regions of initiation (+1 to +59, TAR) or elongation (+496 to +593, luciferase) as illustrated on the top (45) were detected
by qRT-PCR. HeLa cells with an integrated HIV-1 LTR-luciferase gene were pretreated with 400 nM TSA before incubated with 10mM HMBA.
The luciferase activities based on three independent experiments were plotted. (C) Effects of infection with lentivirus expressing scrambled shRNA or
Brd4 shRNA on the levels of HMBA-induced HIV-1 transcription were measured by qRT-PCR (left) as in (B), and the results based on three
independent experiments were plotted, with those untreated with HMBA setting to 1. The efﬁciency of Brd4 knockdown was analyzed by WB with
b-actin as the loading control (right). (D) Chromatin immunoprecipitation (ChIP) assay with anti-Cdk9 antibody for HeLa cells with an integrated
HIV-1 LTR-luciferase gene treated with TSA and/or HMBA. The precipitated DNA was analyzed by real-time PCR with the primers matching to
the promoter region (top), and plotted as the percentage of input (bottom) based on two independent experiments.
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the free P-TEFb that has its Cdk9 re-phosphorylated at
T186 by an unknown kinase, the released Brd4 mediates
the recruitment of the transcriptionally active form of
P-TEFb to the promoter region via the interaction
between Brd4/P-TEFb complex and speciﬁc adaptor
factors. Upon its arrival at the promoter region, P-TEFb
catalyzes the phosphorylation of Ser2 at the CTD of Pol
II, thereby leading to productive elongation. After the ter-
mination of the external signals, the released Brd4
re-associates with the acetyl-nucleosome until the next
round of stimulation. This model incorporates two
signal-induced processes, namely the liberation of
P-TEFb from inactive 7SK snRNP and the release of
Brd4 from chromatin for the subsequent recruitment of
P-TEFb to chromatin to facilitate the expression of
signal-inducible genes.
The observation that almost all Brd4 is associated with
interphase chromatin in untreated cells is intriguing.
Although Brd4 has been found to associate with chromo-
some during mitosis with little free Brd4 elsewhere as
detected by immunoﬂuorescence assays more than a
decade ago (24), whether it has a similar distribution
during interphase is unclear. Our data reveal, for the
ﬁrst time, that almost all Brd4 is associated with chroma-
tin during interphase as well, and that it is a general phe-
nomenon in mammalian cells (Figure 1B and
Supplementary Figure S1). In addition, the observation
that Brd4 re-associates with chromatin after the termin-
ation of stimulation (Figure 2C) indicates that chromatin
targeting is the default feature of Brd4.
How the chromatin-associated Brd4 switches to a tran-
scriptional regulation mode in response to stimulation has
been enigmatic (20). The observation that Brd4 is released
from chromatin upon UV or HMBA treatment
(Figure 2A) provides a pivotal clue to this question. Our
subsequent data demonstrated that the signal-released
Brd4 selectively interacts with the transcriptionally active
Figure 7. A model depicting the signal-induced functional transition of Brd4 from chromatin targeting to transcriptional regulation. In the absence
of the external stimuli, almost all Brd4 is associated with acetylated chromatin (indicated as acetyl-nucleosome). The signals trigger histone H4
deacetylation (red dash line) by activating yet-to-be identiﬁed HDAC(s) (red question mark), which causes the release of Brd4 from chromatin (black
dash line). Meanwhile, the signals also induce the dephosphorylation of Cdk9 at T186 (blue dash line) by the cooperative actions of the activated
phosphatases (PP2B and PP1a), thereby liberating P-TEFb from the inactive 7SK snRNP (19). Through selective association with the transcriptional
active form of P-TEFb that has its Cdk9T-loop re-phosphorylated by unknown kinase(s) (blue question mark), the released Brd4 mediates the
recruitment of active P-TEFb to promoter-proximal region (green dash line), where P-TEFb modulates the processivity of Pol II, thereby leading
to productive elongation. This recruitment is most likely through recognizing adaptor factors, such Mediator or sequence-speciﬁc transcription
factors.
Figure 6. The forced release of endogenous Brd4 from chromatin by
C-mutant of Brd4 augments HIV-1 transcription. (A) The levels of
endogenous Brd4 in LSFs from HeLa cells transfected with empty
vector, HA-tagged C-mutant of Brd4 (HA-C) or HA-tagged PID
(P-TEFb-interacting domain) of Brd4 (HA-PID) were analyzed by
western blotting (WB). The levels of HA-C and HA-PID in cell
lysates were also detected by WB (bottom). (B) Luciferase activities
of HIV-LTR-Luc integrated HeLa cells transfected with indicated
Brd4 mutant constructs were plotted based on three independent
experiments.
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form of P-TEFb (Figure 3) and mediates the recruitment
of this active form of P-TEFb to chromatin (Figures 3
and 4) to enhance the transcription elongation of
signal-inducible gene (Figure 5), thereby uncovering the
transition process of Brd4 from chromatin-targeting
state to transcriptional regulation mode. Of note, the
Brd4 release alone, although essential, is insufﬁcient for
its functional transition, since almost all chromatin-free
P-TEFb is sequestered in the inactive 7SK snRNP in un-
treated cells (Supplementary Figure S2A, left). The
signal-induced liberation of P-TEFb from inactive
complex during treatment (Supplementary Figures S2A,
right and S3C) (19) is also necessary, as demonstrated
by that the enhancement of transcription by the ectopic
expression of HA-C-Brd4 (Figure 6B) is much lower
than that by HMBA treatment (Figure 5A), as
HA-C-Brd4 did not trigger the liberation of P-TEFb
from inactive 7SK snRNP complex (Supplementary
Figure S5D), whereas HMBA did (Figure S3C and refs.
19 and 36).
During UV or HMBA treatment, although the molecu-
lar details of the signal-induced release of Brd4 from chro-
matin are far from clear, the blocking effect of HDAC
inhibitors on Brd4 release (Figure 4A and
Supplementary Figure S3A) suggests that HDAC-
dependent pathway(s) are involved, which is corroborated
by the observation that UV or HMBA treatment triggered
the deacetylation of nucleosomal histone H4K5ac and
H4K8ac (Figure 4C). Whether the deacetylation at both
H4K5 and K8 is necessary for Brd4 release from chroma-
tin is currently unknown, but most likely the deacetylation
at one position is sufﬁcient to weaken the interaction
between Brd4 and chromatin, as Brd4 mutants lacking
either bromodomain associate more weakly with chroma-
tin than the Brd4 with both bromodomains (25). In line
with this feature, the salt-titrated extraction assay showed
that the complete extraction of Brd4 from chromatin
required 0.3M salt in untreated cells, whereas 0.2M salt
is sufﬁcient in cells treated with either UV or HMBA
(Figure 2C). Hence, we may envision that most Brd4
binds to acetylated lysines via both bromodomains in un-
treated cells, and, upon treatment, it loses one or both
contacts with chromatin. Remarkably, although Brd4
has been shown to bind di-acetylated histone H3 at K9/
K14, di-acetylated H4 at K5/K12 and tetra-acetylated H4
at K5/8/12/16 (25), both UV and HMBA only caused the
deacetylation of H4K5ac and H4K8ac but did not change
the acetylation levels at other lysine residues on H3 and
H4 tails (Figure 4C and Supplementary Figure S2B).
Whether such ‘selective deacetylation’ is common for
other types of stimuli and whether it implies a ‘histone
code’ for signal-induced Brd4 release from chromatin
are fascinating questions for future investigation.
The observation that Brd4 interacts with the transcrip-
tionally active form of P-TEFb (Cdk9-T186 phos-
phorylated) in both chromatin-free and -bound fractions
(Figure 3C) seemingly contradicts with our previous
report of Brd4’s association with the inactive form of
P-TEFb (Cdk9-T186 dephosphorylated) (19). This is an
important issue, as the phosphorylation of Cdk9-T186 is
crucial for P-TEFb’s kinase activity (19,36). A major
technical difference is that the dialyzed NE was used in
the previous study (19). Therefore, we compared the phos-
phorylation state of Brd4-associated P-TEFb in dialyzed
versus undialyzed NE, and found that Brd4 in undialyzed
NE selectively binds to the P-TEFb with the phos-
phorylated Cdk9-T186, and that artiﬁcial dephos-
phorylation at Cdk9-T186 of Brd4-bound P-TEFb
occurred during dialysis (see Supplementary Figure
S6A). As the PID (amino acids 1260–1362) region of
Brd4 is responsible for interacting with P-TEFb (26), we
tested whether it possesses selectivity for T186-
phosphorylated Cdk9. Similar to full-length Brd4, PID
also selectively bound to the P-TEFb with fully
phosphorylated Cdk9-T186 in HMBA-treated cells
(Supplementary Figure S6B, lane 2). Collectively, these
data demonstrated that Brd4 selectively interacts with
the transcriptionally active (Cdk9-T186 phosphorylated)
form of P-TEFb.
Since the dephosphorylation at Cdk9-pT186 is necessary
for the liberation of P-TEFb from 7SK snRNP complex
(Figure 3B and ref. 19), the association of Brd4 with
phosphorylated P-TEFb in chromatin-free fraction indi-
cates that re-phosphorylation of Cdk9-T186 of the
liberated P-TEFb should have occurred before P-TEFb is
recruited to chromatin. How the signal-liberated P-TEFb,
which is dephosphorylated at Cdk9 T-loop by the con-
certed action of the activated PP2B and PP1 signal
pathways (19), is converted to the phosphorylated form
remains unclear. The observation that Brd4 could
interact with dephosphorylated P-TEFb in the dialyzed
NE implies that the dephosphorylated P-TEFb might
bind Brd4 initially, but quickly becomes re-phosphorylated
by an unknown kinase thereafter. A most recent study
showed that the calcium/calmodulin-dependent kinase
CaMK1D is involved in the regulation of the stability of
Cdk9 as well as its phosphorylation levels of Cdk9-T186,
but it is unlikely to be a direct kinase for Cdk9-T186 (46).
So, for now, the identity of the kinase for Cdk9-T186 phos-
phorylation remains elusive.
To activate gene expression, Brd4/P-TEFb must be re-
cruited to gene promoters. It has been assumed that the
two bromodomains of Brd4 are responsible for the recruit-
ment of Brd4 to gene promoters during transcriptional
activation. However, if the deacetylation of nucleosomes
leads to the release of Brd4 from chromatin, it is paradox-
ical that Brd4 is recruited to promoters for activating gene
expression. Intuitively, the Brd4-mediated P-TEFb re-
cruitment must be targeted to speciﬁc gene promoters.
Therefore, it is likely that adaptor factors at gene pro-
moters confers speciﬁcity for Brd4 recruitment. It has
been reported that Brd4 co-puriﬁes with Mediator com-
ponents (23,47). Moreover, Brd4 was shown to bind to
acetylated NF-kB for transcriptional activation (48).
Furthermore, Brd4 is able to recruit P-TEFb to naked
DNA template in an in vitro study (22), indicating that
factors other than acetylated nucleosome are at play.
Based on these observations, it is very likely that in
addition to acetylated nucleosomes, adaptors such as
Mediator and/or sequence-speciﬁc transcription factors
can draw Brd4/P-TEFb complex to speciﬁc promoters for
transcriptional activation. During UV/HMBA-induced
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global deacetylation, the adaptors may recruit Brd4/
P-TEFb complex either independent of acetylated
histones or together with locally acetylated histones.
In summary, this study reveals that most Brd4 targets to
chromatin not only in mitosis but also during interphase.
Evidently, not all chromatin-associated Brd4 functions in
P-TEFb recruitment, but a portion of Brd4 on chromatin
is stored in a passive reservoir at unstimulated state. Upon
UV or HMBA treatment, signal-induced histone deacetyl-
ation leads to its release from chromatin, thereby
switching Brd4’s role from chromatin targeting to tran-
scriptional regulation. The proposed missing links such
as the unspeciﬁed HDAC(s) signal pathway for Brd4
release from chromatin, and the unknown kinase for the
re-phosphorylation of Cdk9 T-loop (Figure 7), as well as
the detailed molecular mechanism for recruitment of
Brd4/P-TEFb complex to promoter-proximal region
await future investigation.
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